| FIELD OF APPLICATION | DETAILS |
|---|---|
| Generic Name | Suzetrigine |
| Active Ingredient | Suzetrigine |
| US Brand Names | Journavx (Vertex Pharmaceuticals) |
| Drug Category | Pain Management / Surgery / Orthopedics / Acute Care |
| Drug Class | Selective NaV1.8 Voltage-Gated Sodium Channel Inhibitor (Non-Opioid Peripheral Analgesic) |
| Route of Administration | Oral Tablet |
| FDA Approval Status | FDA approved (January 2025) Approved |
Suzetrigine Overview
Suzetrigine is a prescription non-opioid pain medication used within our Clinic (General Medicine), surgical recovery centers, and outpatient care settings. It is indicated for the management of moderate-to-severe acute pain in adult patients following surgical procedures or acute medical injuries.
What Is Suzetrigine & How Does It Work?
Suzetrigine is a first-in-class, non-opioid selective inhibitor of the voltage-gated sodium channel NaV1.8.
Unlike traditional opioid pain relievers that bind to central opioid receptors in the brain and spinal cord, suzetrigine acts targeted in the peripheral nervous system. The NaV1.8 channel is expressed primarily on peripheral pain-sensing nerves (nociceptors). By selectively blocking these channels, suzetrigine prevents pain signals from being generated and transmitted to the brain. Because it does not cross into or act upon central opioid receptors, it provides effective acute pain relief without risks of physical dependence, addiction, respiratory depression, or opioid-related sedation.
Is Suzetrigine FDA Approved?
Yes, suzetrigine is officially approved by the United States Food and Drug Administration.
What Is Suzetrigine Used For?
- Management of moderate-to-severe acute pain in adult patients.
Before Taking Suzetrigine: Contraindications & Precautions
Healthcare providers perform a complete health evaluation before prescribing suzetrigine for acute pain relief.
Who Should Not Take Suzetrigine?
- Patients with a known severe hypersensitivity or allergic reaction to suzetrigine or any inactive ingredients in the tablet formulation.
- Patients taking strong CYP3A inhibitors concurrently, as drug levels can rise significantly.
Suzetrigine, Pregnancy & Fertility
- Suzetrigine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus, as human clinical data remains limited.
- It is not known whether suzetrigine or its metabolites pass into human breast milk. Nursing mothers should consult their doctor to weigh the benefits of treatment against potential risks to the infant.
- Nonclinical studies have shown no direct evidence of impaired fertility.
Tell Your Doctor Before Taking Suzetrigine
- Disclose any history of moderate or severe liver impairment (hepatic impairment).
- Mention if you have a history of severe kidney disease or kidney failure.
- Inform your provider if you have pre-existing cardiovascular conditions or heart rhythm disorders.
- Provide a complete list of all current prescription medications, over-the-counter remedies, and herbal supplements, particularly those affecting liver enzymes (CYP3A inhibitors or inducers).
Suzetrigine Dosage & Administration
Suzetrigine is taken orally as directed by a healthcare provider for short-term acute pain management.
Standard Suzetrigine Dosing
- Dosing regimens are individualized based on pain severity, clinical setting, and patient response.
- For moderate-to-severe acute pain: Administered as an initial loading dose followed by regular maintenance doses taken every 12 hours as prescribed.
- Treatment duration is typically limited to the acute pain phase (often several days up to two weeks).
How Suzetrigine Is Administered
- Swallow tablets whole with water.
- May be taken with or without food.
- Do not crush, chew, or split the tablets unless explicitly instructed by your physician.
Suzetrigine Clinical Efficacy & Research
Clinical trials demonstrate that suzetrigine provides statistically significant pain relief compared to placebo in patients experiencing moderate-to-severe acute pain after surgical procedures (such as abdominoplasty or bunionectomy). Research confirms that its peripheral mechanism of action delivers robust analgesic efficacy comparable to standard pain management regimens, while avoiding traditional opioid-related side effects like severe constipation, sedation, and addiction potential.
Suzetrigine Side Effects & Safety Profile
This medication does not have an FDA Black Box Warning.
Suzetrigine is generally well tolerated, with a safety profile distinct from both opioids and nonsteroidal anti-inflammatory drugs (NSAIDs).
Suzetrigine Severe Warnings
While suzetrigine does not carry risks of opioid addiction or respiratory depression, significant drug interactions can occur when combined with strong CYP3A4 inhibitors, leading to elevated drug exposure and increased risk of side effects. Dosage adjustments are required in patients with moderate liver impairment.
Suzetrigine Common Side Effects
- Mild to moderate headache.
- Mild dizziness.
- Light nausea or abdominal discomfort.
- Mild constipation (significantly less frequent and severe than opioid-induced constipation).
Serious Suzetrigine Adverse Events
- Severe allergic reactions, including hives, rash, facial swelling, or breathing difficulty.
- Significant elevations in liver enzymes, requiring discontinuation of therapy.
- Marked dizziness or presyncope in susceptible individuals.
Managing Suzetrigine Side Effects
Most common side effects like mild headache or light nausea are temporary and resolve as the body adjusts to the medication. Taking the dose with food can help minimize nausea. If severe allergic symptoms, dark urine, or yellowing of the skin/eyes occur, stop taking the medication and seek emergency medical care immediately.
Interactions & What to Avoid
Suzetrigine is metabolized primarily by liver enzymes, making metabolic interactions important to monitor.
Suzetrigine Interactions
- Strong CYP3A4 inhibitors (such as ketoconazole, itraconazole, or clarithromycin) increase suzetrigine exposure and should be avoided or managed with dose reductions.
- Strong CYP3A4 inducers (such as rifampin, carbamazepine, or St. John’s wort) can lower suzetrigine levels in the blood, reducing its pain-relieving efficacy.
- Co-administration with other non-opioid analgesics (like acetaminophen or ibuprofen) may be used under clinical supervision for multimodal pain therapy.
Food & Alcohol
- Grapefruit and grapefruit juice (strong CYP3A4 inhibitors) should be avoided while taking suzetrigine to prevent elevated drug concentrations.
- Alcohol consumption should be limited, as combining alcohol with pain medications can increase dizziness and liver strain.
Suzetrigine Missed Dose, Overdose & Storage
Proper storage and compliance support safe and effective acute pain recovery.
Missed Dose of Suzetrigine
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed tablet and resume your regular dosing schedule. Do not take two doses at the same time to make up for a missed dose.
Suzetrigine Overdose & Emergency
An overdose of suzetrigine may cause severe dizziness, pronounced headache, nausea, or metabolic shifts. If an accidental overdose occurs, seek immediate emergency medical attention or contact a poison control center. Treatment involves supportive care and clinical monitoring.
How to Store Suzetrigine
Store tablets at controlled room temperature between 20°C and 25°C (68°F and 77°F). Protect from excessive heat and moisture. Keep the bottle tightly closed and stored safely out of reach of children and pets.
Suzetrigine Patient Management & Monitoring
Patients taking suzetrigine for acute pain are evaluated periodically during recovery.
Tests Before Starting Suzetrigine
- Baseline assessment of pain severity and clinical etiology.
- Review of liver and kidney function tests for patients with pre-existing organ impairment.
- Screening for concurrent medications metabolized by the CYP3A pathway.
Monitoring During Suzetrigine Routine
- Re-evaluation of pain relief and functional recovery.
- Monitoring for potential side effects, such as persistent headache or dizziness.
- Tracking treatment duration to ensure therapy is stopped once acute pain resolves.
Suzetrigine Do’s and Don’ts
- Do take your doses at evenly spaced intervals as prescribed by your doctor.
- Do inform your doctor of all other pain relief products or supplements you are taking.
- Don’t consume grapefruit or grapefruit juice while taking this medication.
- Don’t share your prescribed pain tablets with others, even if they have similar pain symptoms.
Frequently Asked Questions
What is suzetrigine used for?
Suzetrigine is a non-opioid prescription medicine used to treat moderate-to-severe acute pain in adults, such as pain following surgical operations or acute injuries.
Is suzetrigine an opioid or narcotic?
No. Suzetrigine is a non-opioid pain medication. It works by blocking specific peripheral pain channels (NaV1.8) on nerve cells rather than activating opioid receptors in the brain, so it carries no risk of addiction, physical dependence, or opioid abuse.
How does suzetrigine differ from NSAIDs like ibuprofen or naproxen?
While NSAIDs work by reducing inflammation through COX enzyme inhibition, suzetrigine directly blocks the NaV1.8 sodium channels that send pain signals along peripheral nerves. It provides targeted pain relief without the stomach ulcer or kidney risks associated with high-dose NSAID use.
Will suzetrigine cause severe constipation or sedation like opioids?
Because suzetrigine does not act on central opioid receptors, common opioid side effects, such as severe constipation, extreme drowsiness, slowed breathing, and brain fog, are far less common or absent.
Can I take suzetrigine with other pain relievers like acetaminophen?
In many post-operative settings, doctors use multimodal pain strategies. You should only combine suzetrigine with acetaminophen, NSAIDs, or other pain relievers if explicitly instructed to do so by your healthcare provider.
How long can I take suzetrigine?
Suzetrigine is intended for short-term use during the acute pain phase (typically several days up to two weeks after surgery or injury). Your doctor will advise you on when to taper off or stop taking the medication as your pain improves.
What should I do if I feel dizzy after taking suzetrigine?
Mild dizziness can occur. Rest in a seated or reclining position until the feeling passes. Avoid driving, operating machinery, or performing hazardous tasks if you feel lightheaded or dizzy. If dizziness is severe or persistent, contact your prescribing physician.
References
- U.S. FDA – Journavx (suzetrigine) prescribing information
- U.S. FDA Drugs@FDA – Drug approval overview
- National Institutes of Health (NIH) – Peripheral NaV1.8 sodium channels in acute pain management
Legal Disclaimer
The information provided is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider at any hospital or any local clinic before starting or stopping any medication.
